SCHEMBL7872792

SCHEMBL7872792

FC(F)(F)c1ccc(-c2nc3c(o2)CCC(c2ncccc2C2CN2)C3)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.35
S1PR3 Q99500 2/20 0.35
S1PR5 Q9H228 2/20 0.35
GPR119 Q8TDV5 5/20 0.34
NPC1 O15118 1/20 0.34
P2RX7 Q99572 2/20 0.33
PRCP P42785 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
BACE1 P56817 1/20 0.33
CTSS P25774 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.32
CACNA1B Q00975 1/20 0.32
SYK P43405 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882208 1.00 S1PR1 (0.35) S1PR1S1PR3S1PR5GPR119NPC1
SCHEMBL7877288 0.89 GPR119 (0.36) GPR119PRCPACHEALDH1A1
SCHEMBL7883808 0.88 GPR119 (0.44) GPR119NPC1PRCPCYP1A2CYP2C19
SCHEMBL7879696 0.84 NPC1 (0.35) S1PR5GPR119NPC1PRCPACHE
SCHEMBL505373 0.83 GRM5 (0.44) S1PR1S1PR3S1PR5NPC1BCHE
SCHEMBL7880996 0.78 RAB9A (0.43) GPR119NPC1KDM4EALDH1A1HSD17B10
SCHEMBL7877057 0.77 GPR119 (0.43) S1PR5GPR119NPC1PRCPCYP1A2
SCHEMBL505639 0.76 NPC1 (0.39) S1PR1S1PR3S1PR5NPC1TRPV1
SCHEMBL7880734 0.72 GRM5 (0.36) GPR119PRCPACHE
SCHEMBL505982 0.72 GRM5 (0.46) GPR119PRCPACHEKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010114971-A1 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SEPRACOR INC. (US) 2010-10-07 WO disclosed